People who were infected with an earlier version of the coronavirus and received three doses of an mRNA vaccine – such as the Pfizer/BioNTech shot – appear to be best protected against symptomatic infection by the Omicron variant, according to a large study. Additionally, COVID-19-related neurological symptoms – such as memory and concentration issues – can last half a year or more in some patients, according to a small study.